Bio-Rad Labs (BIO) Tops Q3 EPS by 53c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $304.77 +1.26%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
UBAB, LOAN, FITB, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.91, $0.53 better than the analyst estimate of $0.38. Revenue for the quarter came in at $535 million versus the consensus estimate of $508 million.
GUIDANCE:
Bio-Rad Labs sees Q4 2017 revenue of $615-625 million, versus the consensus of $633 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan upgrades 3M, Emerson Electric to Overweight ahead of earnings
- Citizens Financial Group (CFG) PT Raised to $85 at DA Davidson
- General Aerospace (GE) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
